For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.

At a time when insurers are backing away from coverage for weight loss medications, President Trump has offered a lifeline ...

Eli Lilly (LLY) partners with SanegeneBio in a deal worth up to $1.2B to develop and commercialize RNAi therapeutics for ...

Florness knows Fastenal inside and out. An accountant by training, he joined the Winona-based industrial supplier in 1996 as ...

Eli Lilly's Mounjaro and Zepbound deliver accelerated weight loss rates compared to Novo Nordisk's Wegovy. Learn why LLY ...

Berkshire Hathaway's diversification, culture, and investment philosophy should still make it a great long-term buy, but ...

As the buzz around GLP-1 medications grew to a fever pitch over the past two years, many digital health and telehealth ...

The Trump administration announced new agreements Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly to lower the cost of GLP-1 drugs for many Americans, including those on Medicare.

Get the latest news and live updates as the government shutdown enters Day 37, with FAA cuts to flights and energy bill assistance cuts looming.

At the White House, President Trump announced a deal to make weight loss drugs more affordable. Mr. Trump says drug makers ...

The Trump administration on Thursday announced a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims to deliver lower prices for their popular GLP-1 drugs to certain Medicare ...

The drugs are part of a new generation of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...